Discover how automation, AI, and organoid technologies are improving drug discovery through scalable workflows.

FuelCell Energy (FCEL) rose 10.2% in premarket trade on Monday  after securing a $49 million clean energy technology export ...

M ore than a decade ago, the economist Erik Brynjolfsson made a prediction: AI would change everything. Humans began using ...

AI drug discovery cleared its first Phase IIa clinical test in 2025, as BIO 2026 confirmed the shift from speculation to ...

Anthropic accused Alibaba of conducting the largest adversarial distillation campaign ever documented against its Claude AI, telling the U.S. Senate on Wednesday that operators linked to Alibaba's ...

A slew of start-ups and academic labs are leaning on AI agents and bots, rather than humans, to speed up their chemistry ...

Schools in the US are set to introduce a humanoid robot into classrooms as ...

The growing importance of infrastructure leaders who can bridge technical architecture with large-scale execution ...

AI startup Mirendil raised $200 million in seed funding at a $1 billion valuation, one of the largest AI seed rounds to date. Founded by former researchers from Anthropic, OpenAI, Google DeepMind, and ...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ VANCOUVER, BC, /CNW/ - Light AI Inc. ("Light AI" or the "Company") (CBOE C ...

OpenAI's new Jalapeño inference chip promises faster performance, improved efficiency, and lower computing costs.

The physical AI platform, named AI Experimentalist, translates research goals from natural language into experiments at scale.